Spring direct naar de hoofdnavigatie of de inhoud
‘The best results are obtained when there is an exchange of creative thinking between the patent attorney and the client. I truly enjoy achieving and maintaining such synergy.’
Home / Experts / Annemiek Tepper
Annemiek Tepper

Annemiek Tepper

  • Chemistry
  • Life Sciences
  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
T +31 50 599 52 24

Annemiek Tepper joined V.O. in 2002. During her academic career, she spent one year at the University of Chapel Hill (USA) and at the Pasteur Institute in Paris. Annemiek studied biochemistry at the University of Groningen. She obtained her PhD at the Netherlands Cancer Institute (Amsterdam).

Continue reading

Her specialties include biochemistry, biotechnology, oncology, immunology, diagnostics, medical technology, dairy science and food technology. She is actively involved in assessing the patentability of new developments, and in drafting and prosecuting patent applications worldwide. Other activities include evaluating third party patent portfolios and providing opinions of validity/invalidity and infringement/non infringement. She is also experienced in representing clients in opposition and appeal cases before the EPO. Her clients are diverse and range from academic institutions, SME’s to multinationals.

In her capacity as European Patent Litigator, Annemiek is allowed to act as UPC representative.

Working experience

  • Patent Attorney, V.O. (2006-present)
  • Post-Doc, Academic Medical Center (2000-2002)

Education

  • PhD, Faculty of Science, University of Amsterdam (2000, with honours)
  • MSc in Biochemistry, University of Groningen (1994, with honours)

Directories

  • Highlighted as ‘exceptional attorney’ by IP Stars Handbook MIP, 2016.

Publications

  • Tepper AD, Ruurs P, Borst J, van Blitterswijk WJ (2001) Biochim. Biophys. Res. Commun. 280:634
  • Tepper AD, Diks SH, van Blitterswijk WJ, Borst J (2000) J. Biol. Chem. 275:34810
  • Tepper AD, Ruurs P, Wiedmer T, Sims PJ, Borst J, van Blitterswijk WJ (2000) J. Cell Biol. 150:155
  • Tepper AD and van Blitterswijk WJ (2000) Methods Enzymol. 312:16
  • Tepper AD, de Vries E, van Blitterswijk WJ, Borst J (1999) J. Clin. Invest. 103:971
  • Tepper AD, Boesen-de Cock JG, de Vries E, Borst J, van Blitterswijk WJ (1999) J. Biol. Chem. 272:24308
  • Boesen-de Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J (1999) J.Biol. Chem. 274:14255
  • Borst P, van Blitterswijk WJ, Borst J, Tepper AD, Schinkel AH (1998) Drug Resistance Update 1:337
  • Boesen-de Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J (1998) J. Biol. Chem. 273:7560
  • Tepper AD, Dammann H, Bominaar AA, Véron M (1994) J. Biol. Chem. 269:32175
  • Véron M, Tepper A, Hildebrandt M, Lascu I, Lacombe ML, Janin J, Moréra S, Cherfils J, Dumas C, Chiadmi M (1994) Adv. Exp. Med. Biol. 370:607
  • Bominaar AA, Tepper AD, Véron M (1994) FEBS Lett. 353(1):5

Professional & Community Activities

  • Member of the Committee ‘professional orientation’ of the Dutch Patent Association (Orde van Octrooigemachtigden) aimed to promote the profession of patent attorney
  • EPI Tutor

Languages

  • English
  • Dutch

See also

Also see these experts

Tamara Idema

Tamara Idema

  • European and Dutch Patent Attorney, European Patent Litigator
  • Associate
+31 20 530 79 85
Frits Schut

Frits Schut

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
+31 70 416 67 45
More experts

News

Netherlands Patent Attorney Firm of the Year

Since October 17, V.O. can proudly call itself “Netherlands Patent Attorney Firm of the Year. On behalf of our firm, Sjoerd Postma and Marijke Westra received this honorable award from IAM and WTR in London, where all winners of the 2024 Global IP Award were announced.Continue reading

Research exemptions under Belgian patent law before and after 1 June 2023

A research exemption is a provision in patent law that allows researchers to perform Research and Development (R&D) on patented inventions without infringing on the patent holder’s rights. In Belgium, the research exemption was one of the broadest in Europe until 31 May 2023.Continue reading

Recognitions by IP STARS andWho’s Who Legal

We are again proud of our recent recognitions by IP STARS (Managing IP) as a Tier 1 firm and for Belgium as a Tier 2 firm. And a Tier 3 listing for Trademark Prosecution. Individual recommendations as ‘IP Stars 2024’ are for Tamara Elmore, Bettina Hermann, Annemie Jaeken, Leo Jessen, Bernard Ledeboer, Marco Molling, Otto […]Continue reading

More news

Events

Dutch Life Sciences Conference 2024

Willem Einthovenstraat 1, Oegstgeest

Dutch Life Sciences conference is the Netherlands´ most established life sciences event. It has positioned itself as the premier annual meeting place for both Dutch and international players. The event brings together leading CEOs of biotech, pharma and medical devices companies, heads of R&D, academics, and life sciences investors for networking opportunities and stimulates the exchange of scientific ideas and collaboration.

Continue reading

More events